Bioequivalence of Metformin in Ertugliflozin/Metformin Fixed‐Dose Combination Tablets to Canadian‐Sourced Metformin Coadministered With Ertugliflozin Under Fasted and Fed States

A fixed‐dose combination (FDC) product of a selective sodium‐glucose cotransporter 2 inhibitor ertugliflozin and immediate‐release metformin is approved for type 2 diabetes mellitus in the United States, European Union countries, Canada, and other countries. Two studies were conducted to assess the...

詳細記述

保存先:
書誌詳細
出版年:Clin Pharmacol Drug Dev
主要な著者: Dawra, Vikas Kumar, Pelletier, Kathleen, Matschke, Kyle, Shi, Haihong, Hickman, Anne, Zhou, Susan, Krishna, Rajesh, Sahasrabudhe, Vaishali
フォーマット: Artigo
言語:Inglês
出版事項: John Wiley and Sons Inc. 2020
主題:
Articles
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC8246554/
https://ncbi.nlm.nih.gov/pubmed/33135865
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpdd.884
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料